BPA for pluvicto and lutathera injection

Active Awarded

Contract number
HT941026FE110
Awardee
Awarding agency
Obligated
$205,766

Award facts

Contract value 100% obligated
$205,765.56 Current and potential, with all options
Completion date 33% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
East Hanover, NJ 07936, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Novartis Pharmaceuticals Corporation on July 21, 2026, for PLUVICTO and LUTATHERA injection with a ceiling value of $205,765.56. Performance occurs in East Hanover, New Jersey, and concludes April 30, 2027. The call is firm fixed price with no set-aside. PLUVICTO (Lutetium Lu-177 vipivotide tetra) and LUTATHERA (Lutetium Lu-177 dotatate) are radiopharmaceutical therapies for advanced cancers—metastatic castration-resistant prostate cancer and neuroendocrine tumors, respectively. Novartis competes under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC category Drugs and Biologicals as a foreign-owned pharmaceutical manufacturer.

Quick answers

Who was awarded contract HT941026FE110?

HT941026FE110 was awarded to Novartis Pharmaceuticals Corporation by Defense Health Agency (Department of Defense) on July 21, 2026.

How much is contract HT941026FE110 worth?

The government has obligated $205,766 on HT941026FE110.

Is contract HT941026FE110 an order under another contract?

Yes. HT941026FE110 is a BPA call under HT941026AE002, a blanket purchase agreement.

Was contract HT941026FE110 competed?

The extent of competition for HT941026FE110 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award